| Does participation in clinical trials influence the costs of future management of patients? | |
| | |
MedLine Citation:
|
PMID: 22072320 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: An earlier study showed that from a societal perspective it was less expensive to encourage patients to self-regulate their medication for GERD (gastro-esophageal reflux disease) by treating patients on-demand. OBJECTIVE: The objective was to investigate whether physician involvement in a clinical trial financed by the pharmaceutical industry subsequently results in higher health care costs. STUDY DESIGN: An open, observational, multicenter study compared direct medical costs and total costs for three groups of patients with different exposure to the clinical trial; (1) Dual exposed, where both the patients and the GP participated in the former clinical trial, (2) GP exposed, where only the GP participated in the former clinical trial and (3) nonexposed, where neither the patients nor the GP participated in the former clinical trial. RESULTS: We did not find any statistically significant differences in neither direct medical nor total costs. However, we did observe a numerical difference in direct medical costs of 24% higher in the dual exposed group compared to the nonexposed group mainly due to a higher consumption of prescribed medication. The higher direct medical cost in the dual exposed group was however counterbalanced by lower observed direct nonmedical and indirect costs. CONCLUSION: Although we did not find any statistical significant differences in health care costs, we did observe a higher consumption of prescribed medication and lower costs of work hours lost if both patient and GPs participated in a former clinical trial. The results may be limited due to a lower number of patients included than expected. |
| | |
Authors:
|
Anne Hvenegaard; Henrik Hauschildt Juhl; Andreas Habicht |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-10 |
Journal Detail:
|
Title: The European journal of health economics : HEPAC : health economics in prevention and care Volume: - ISSN: 1618-7601 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101134867 Medline TA: Eur J Health Econ Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Danish Institute for Health Services Research, 27-29 Dampfaergevej, 2100, Copenhagen, Denmark, ah@dsi.dk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: RANK-dependent autosomal recessive osteopetrosis: characterisation of 5 new cases with novel mutatio...
Next Document: Trends in social class inequalities in the use of health care services within the Spanish National H...